Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 3.87%497.1M | 18.25%174.27M | 1.44%152.27M | -8.39%120.97M | 1.09%49.59M | 118.42%478.58M | 82.05%147.37M | 56.05%150.11M | 757.13%132.05M | 84.65%49.06M |
Net income from continuing operations | 89.66%270.92M | 176.16%117.19M | 62.92%65.39M | 35.65%54.57M | 68.46%33.76M | 32.02%142.85M | 32.00%42.44M | 33.10%40.14M | 52.55%40.23M | 2.65%20.04M |
Operating gains losses | -1,692.70%-94.76M | -7,626.52%-91.48M | 78.52%-316K | -148.07%-2.38M | 65.01%-585K | 75.92%-5.29M | 93.15%-1.18M | -8.40%-1.47M | -67.95%-959K | 39.11%-1.67M |
Depreciation and amortization | 19.17%68.41M | 20.10%17.86M | 16.87%17.36M | 21.07%16.93M | 18.74%16.26M | 10.25%57.4M | 10.05%14.87M | 13.08%14.86M | 2.46%13.98M | 16.36%13.69M |
Deferred tax | 120.89%32.57M | 480.65%26.47M | -23.78%2.59M | -50.76%2M | -44.39%1.52M | -59.59%14.75M | -60.42%4.56M | -67.55%3.4M | -54.18%4.06M | -51.63%2.73M |
Other non cash items | -33.64%1.15M | -31.55%269K | -38.73%280K | -35.82%292K | -27.73%305K | -19.15%1.73M | -21.40%393K | -14.42%457K | -16.67%455K | -24.10%422K |
Change In working capital | -20.87%199.82M | 19.44%98.71M | -29.48%62.59M | -36.52%44.76M | -158.91%-6.25M | 757.48%252.53M | 130.90%82.65M | 119.05%88.76M | 295.46%70.52M | 198.38%10.61M |
-Change in receivables | -17.26%194.85M | 26.26%131.63M | -29.60%49.98M | -114.09%-5.63M | -7.12%18.86M | 2,412.40%235.49M | 30.66%104.25M | 1,420.00%71M | 164.31%39.93M | 256.25%20.31M |
-Change in payables and accrued expense | -24.90%11.38M | -17.35%-32.63M | -37.86%11.39M | 60.72%47.64M | -199.24%-15.03M | -20.74%15.15M | 42.23%-27.81M | -46.77%18.33M | 8.20%29.64M | -192.95%-5.02M |
-Change in other current assets | 97.67%-131K | 199.66%296K | 185.10%1.61M | -1.97%-1.97M | 95.34%-70K | -403.89%-5.62M | -108.91%-297K | -685.06%-1.89M | -1,344.52%-1.93M | -7.21%-1.5M |
-Change in other working capital | -183.54%-6.28M | -108.99%-584K | -129.94%-394K | 63.85%4.71M | -215.01%-10.01M | 949.66%7.51M | 715.06%6.5M | -20.19%1.32M | 286.70%2.88M | -77.64%-3.18M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 3.87%497.1M | 18.25%174.27M | 1.44%152.27M | -8.39%120.97M | 1.09%49.59M | 118.42%478.58M | 82.05%147.37M | 56.05%150.11M | 757.13%132.05M | 84.65%49.06M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -111.79%-185.85M | -98.90%-123.55M | -81.89%-16.92M | -6.55%-24.33M | -423.55%-21.05M | 2.23%-87.75M | -48.13%-62.12M | 44.61%-9.3M | -38.72%-22.84M | 144.67%6.51M |
Capital expenditure reported | -25.75%-80.95M | -3.37%-15.65M | -34.81%-14M | -17.21%-28.88M | -57.74%-22.43M | -5.70%-64.38M | -15.74%-15.14M | 45.02%-10.39M | -76.29%-24.64M | 5.00%-14.22M |
Net PPE purchase and sale | -26.42%10.16M | -44.65%2.32M | -17.74%890K | 152.53%4.54M | -64.30%2.4M | 179.04%13.8M | 120.43%4.2M | -48.28%1.08M | 230.09%1.8M | 1,556.65%6.73M |
Net business purchase and sale | -209.47%-115.05M | -115.38%-110.23M | ---3.81M | --0 | -107.26%-1.02M | -10.01%-37.18M | -66.38%-51.18M | --0 | --0 | --14M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -111.79%-185.85M | -98.90%-123.55M | -81.89%-16.92M | -6.55%-24.33M | -423.55%-21.05M | 2.23%-87.75M | -48.13%-62.12M | 44.61%-9.3M | -38.72%-22.84M | 144.67%6.51M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -13.48%-118.62M | -50.09%-34.65M | -185.59%-27.21M | -0.76%-37.07M | 43.94%-19.69M | -218.81%-104.53M | -201.58%-23.09M | -59.38%-9.53M | -529.68%-36.79M | -163.88%-35.13M |
Net issuance payments of debt | 70.81%-26.54M | 53.06%-6.61M | 28.66%-6.61M | 81.91%-6.65M | 78.35%-6.68M | -289.03%-90.93M | -144.38%-14.08M | -58.52%-9.26M | -529.00%-36.75M | -420.29%-30.84M |
Net common stock issuance | ---70.6M | ---20M | ---20.45M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Net other financing activities | -57.94%-21.49M | 10.70%-8.05M | 43.82%-150K | -592.50%-277K | -203.52%-13.02M | -44.49%-13.61M | -375.46%-9.01M | -96.32%-267K | ---40K | 41.94%-4.29M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -13.48%-118.62M | -50.09%-34.65M | -185.59%-27.21M | -0.76%-37.07M | 43.94%-19.69M | -218.81%-104.53M | -201.58%-23.09M | -59.38%-9.53M | -529.68%-36.79M | -163.88%-35.13M |
Net cash flow | ||||||||||
Beginning cash position | 154.53%471.56M | 58.31%648.13M | 94.15%539.99M | 137.15%480.41M | 154.53%471.56M | 108.88%185.27M | 166.01%409.4M | 245.56%278.12M | 131.82%202.58M | 108.88%185.27M |
Current changes in cash | -32.72%192.63M | -74.15%16.07M | -17.62%108.14M | -17.75%59.57M | -56.68%8.85M | 196.46%286.3M | 98.24%62.17M | 78.80%131.28M | 1,149.62%72.42M | 1,662.08%20.43M |
End cash Position | 40.85%664.2M | 40.85%664.2M | 58.31%648.13M | 94.15%539.99M | 137.15%480.41M | 154.53%471.56M | 154.53%471.56M | 166.01%409.4M | 245.56%278.12M | 131.82%202.58M |
Free cash flow | 0.47%416.15M | 19.96%158.62M | -1.04%138.27M | -14.26%92.09M | -22.04%27.16M | 161.81%414.21M | 94.83%132.23M | 80.74%139.72M | 7,411.26%107.41M | 200.34%34.84M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |